Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8452144 | Experimental Cell Research | 2017 | 9 Pages |
Abstract
The 37Â kDa/67Â kDa laminin receptor (LRP/LR) serves various physiological and pathological roles such as enhancing tumour-related processes including metastasis, angiogenesis, cellular viability and telomerase activation in cancerous cell lines. The present study investigates the effect of siRNA mediated downregulation of LRP/LR on pancreatic cancer (AsPC-1) and neuroblastoma (IMR-32) cells. MTT and BrdU assays revealed that siRNA mediated downregulation of LRP resulted in a significant reduction in cell viability and cell proliferation. In addition, knock-down of LRP resulted in phosphatidylserine externalization, diminished nuclear integrity and significantly enhanced caspase-3 activity, which is indicative of apoptosis. LRP downregulation resulted in a significant increase in caspase-8 activity in IMR-32 cells and enhanced caspase-8 and 9 activity in AsPC-1 cells. These data recommend siRNA mediated knock-down of LRP as a potential therapeutic avenue for the treatment of pancreatic cancer and neuroblastoma.
Keywords
BCAIMR-32AsPC-1EMEMPAGEHRPLRPFITCFBSIgGSDShTERTPCASmall interfering RNAsmall interfering RNAssiRNAEDTAEthylenediaminetetraacetic acidprotocatechuic acidpolyacrylamide gel electrophoresisBrdUbromodeoxyuridinebicinchoninic acidEnzyme-linked immunosorbent assayELISAhuman telomerase reverse transcriptaseApoptosissodium dodecyl sulphatePancreatic cancerfetal bovine serumPancreatic cancer cellsNeuroblastoma cellsfluorescein isothiocyanateNeuroblastomahorse radish peroxidaselaminin receptor
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Carryn J. Chetty, Eloise Ferreira, Katarina Jovanovic, Stefan F.T. Weiss,